Sintx Technologies (NASDAQ:SINT – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, earnings and profitability.
Insider & Institutional Ownership
18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by company insiders. Comparatively, 7.1% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Volatility and Risk
Sintx Technologies has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 1.88, meaning that its share price is 88% more volatile than the S&P 500.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sintx Technologies | $738,000.00 | 8.19 | -$10.36 million | ($5.07) | -0.28 |
| Envoy Medical | $234,000.00 | 217.73 | -$23.76 million | ($1.01) | -0.66 |
Sintx Technologies has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Sintx Technologies and Envoy Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sintx Technologies | -1,058.60% | -366.49% | -115.04% |
| Envoy Medical | -9,875.64% | N/A | -177.92% |
Analyst Ratings
This is a summary of recent ratings for Sintx Technologies and Envoy Medical, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sintx Technologies | 1 | 0 | 3 | 0 | 2.50 |
| Envoy Medical | 1 | 1 | 1 | 0 | 2.00 |
Sintx Technologies presently has a consensus price target of $9.33, indicating a potential upside of 566.67%. Envoy Medical has a consensus price target of $2.50, indicating a potential upside of 277.24%. Given Sintx Technologies’ stronger consensus rating and higher probable upside, analysts plainly believe Sintx Technologies is more favorable than Envoy Medical.
Summary
Sintx Technologies beats Envoy Medical on 9 of the 14 factors compared between the two stocks.
About Sintx Technologies
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
